JPRN-jRCT2080221438未知3 期
Phase III Clinical Study of AJG522 : Studies of safety and efficacy of AJG522 as a colon preparation agent for colonoscopy - Comparative study with MGV-5
Ajinomoto Pharmaceuticals Co., Ltd.0 个研究点开始时间: 2011年4月21日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients scheduled for colonoscopy.
排除标准
- •- Presence or suspicion of gastrointesinal ileus, intestinal perforation or toxic megacolon.
- •- Renal impairment.
研究者
相似试验
未知
3 期
Phase III study of AJG511 in patients with active ulcerative colitisulcerative colitisJPRN-jRCT2080222653EA Pharma Co.,Ltd.120
未知
2 期
Phase II/III induction study of AJG501 in patients with active ulcerative colitislcerative colitisJPRN-jRCT2080221110Ajinomoto Pharmaceuticals Co., Ltd.
未知
3 期
Phase 3 study of AJG533 in patients with chronic constipatioChronic constipationJPRN-jRCT2080223008EA Pharma Co.,Ltd.120
未知
2 期
Phase II study of AJG511 in patients with active ulcerative colitislcerative colitisJPRN-jRCT2080222245Ajinomoto Pharmaceuticals Co., Ltd.
未知
3 期
ong term study of AJG533 in patients with chronic constipatioChronic constipationJPRN-jRCT2080223007EA Pharma Co.,Ltd.360